A Study to Evaluate SHR-1210 in Subjects With Advanced HCC
NCT02989922
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
220
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatocellular Carcinoma Non-Resectable
Interventions
BIOLOGICAL:
SHR-1210
Sponsor
Jiangsu HengRui Medicine Co., Ltd.